{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Pueraria lobata", "acamprosate", "alcohol intake", "alcohol preferring rats", "alcohol tolerance", "daidzin", "ghrelin blood level", "naltrexone", "puerarin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35056082", "DateRevised": {"Year": "2022", "Month": "01", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "24"}], "Language": ["eng"], "ELocationID": ["25", "10.3390/ph15010025"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "15", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "24"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Differential Influence of <i>Pueraria lobata</i> Root Extract and Its Main Isoflavones on Ghrelin Levels in Alcohol-Treated Rats.", "Abstract": {"AbstractText": ["The study was carried out on alcohol-preferring male Wistar rats. The following drugs were repeatedly (28\u00d7) administered: acamprosate (500 mg/kg, p.o.), naltrexone (0.1 mg/kg, i.p), and <i>Pueraria lobata</i> (kudzu) root extract (KU) (500 mg/kg, p.o.) and its isoflavones: daidzin (40 mg/kg, p.o.) and puerarin (150 mg/kg, p.o.). Their effects on a voluntary alcohol intake were assessed. KU and alcohol were also given for 9 days in an experiment on alcohol tolerance development. Finally, total and active ghrelin levels in peripheral blood serum were measured by ELISA method. Acamprosate, naltrexone, daidzin, and puerarin, reducing the alcohol intake, caused an increase in both forms of ghrelin levels. On the contrary, though KU inhibited the alcohol intake and alcohol tolerance development, it reduced ghrelin levels in alcohol-preferring rats. The changes of ghrelin concentration could play a role as an indicator of the currently used drugs. The other effect on the KU-induced shift in ghrelin levels in the presence of alcohol requires further detailed study."]}, "AuthorList": [{"Identifier": ["0000-0003-3295-2789"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Pozna\u0144 University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland."}], "LastName": "Szulc", "ForeName": "Micha\u0142", "Initials": "M"}, {"Identifier": ["0000-0002-2389-0689"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Pozna\u0144 University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland."}], "LastName": "Kujawski", "ForeName": "Rados\u0142aw", "Initials": "R"}, {"Identifier": ["0000-0001-7533-3078"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Baraniak", "ForeName": "Justyna", "Initials": "J"}, {"Identifier": ["0000-0003-0128-6680"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Kania-Dobrowolska", "ForeName": "Ma\u0142gorzata", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Pozna\u0144 University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland."}], "LastName": "Kami\u0144ska", "ForeName": "Ewa", "Initials": "E"}, {"Identifier": ["0000-0002-8164-9914"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Gryszczy\u0144ska", "ForeName": "Agnieszka", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Pozna\u0144 University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland."}], "LastName": "Czora-Poczwardowska", "ForeName": "Kamila", "Initials": "K"}, {"Identifier": ["0000-0002-9612-3819"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Pozna\u0144 University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland."}], "LastName": "Winiarska", "ForeName": "Hanna", "Initials": "H"}, {"Identifier": ["0000-0002-1252-6523"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Pozna\u0144 University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Miko\u0142ajczak", "ForeName": "Przemys\u0142aw \u0141", "Initials": "P\u0141"}], "GrantList": [{"GrantID": "Grant No. NN 405 358737", "Agency": "Polish Ministry of Science and Higher Education", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare that they have no competing interest. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Shield K.D., Parry C., Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res. 2013;35:155\u2013173.", "ArticleIdList": ["PMC3908707", "24881324"]}, {"Citation": "Ramalho R. Alcohol consumption and alcohol-related problems during the COVID-19 pandemic: A narrative review. Australas. Psychiatry. 2020;28:524\u2013526. doi: 10.1177/1039856220943024.", "ArticleIdList": ["10.1177/1039856220943024", "32722961"]}, {"Citation": "Institute of Medicine. National Research Council. Division of Behavioral and Social Sciences and Education. Board on Children, Youth, and Families. Committee on Developing a Strategy to Reduce and Prevent Underage Drinking . Reducing Underage Drinking: A Collective Responsibility. National Academies Press; Washington, DC, USA: 2004."}, {"Citation": "Gilburt H., Drummond C., Sinclair J. Navigating the Alcohol Treatment Pathway: A Qualitative Study from the Service Users\u2019 Perspective. Alcohol Alcohol. 2015;50:444\u2013450. doi: 10.1093/alcalc/agv027.", "ArticleIdList": ["10.1093/alcalc/agv027", "PMC4474003", "25825267"]}, {"Citation": "Klimas J., Fairgrieve C., Tobin H., Field C.-A., O\u2019Gorman C.S., Glynn L.G., Keenan E., Saunders J., Bury G., Dunne C., et al. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Cochrane Database Syst. Rev. 2018;12:CD009269. doi: 10.1002/14651858.CD009269.pub4.", "ArticleIdList": ["10.1002/14651858.CD009269.pub4", "PMC6517179", "30521696"]}, {"Citation": "National Institute on Drug Abuse  Principles of Effective Treatment.  [(accessed on 22 September 2021)]; Available online:  https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/principles-effective-treatment."}, {"Citation": "O\u2019Malley S.S., O\u2019Connor P.G. Medications for unhealthy alcohol use: Across the spectrum. Alcohol Res. Health. 2011;33:300\u2013312.", "ArticleIdList": ["PMC3860540", "23580015"]}, {"Citation": "Witkiewitz K., Litten R.Z., Leggio L. Advances in the science and treatment of alcohol use disorder. Sci. Adv. 2019;5:eaax4043. doi: 10.1126/sciadv.aax4043.", "ArticleIdList": ["10.1126/sciadv.aax4043", "PMC6760932", "31579824"]}, {"Citation": "Zhang S., Wang J., Zhao H., Luo Y. Effects of three flavonoids from an ancient traditional Chinese medicine on geriatric diseases. Brain Circ. 2018;4:174\u2013184.", "ArticleIdList": ["PMC6329217", "30693344"]}, {"Citation": "Keung W.M. Anti-dipsotropic isoflavones: The potential therapeutic agents for alcohol dependence. Med. Res. Rev. 2003;23:669\u2013696. doi: 10.1002/med.10049.", "ArticleIdList": ["10.1002/med.10049", "12939789"]}, {"Citation": "Overstreet D.H., Lee D.Y.-W., Chen Y.T., Rezvani A.H. The Chinese herbal medicine NPI-028 suppresses alcohol intake in alcohol-preferring rats and monkeys without inducing taste aversion. Focus Altern. Complement. Ther. 2010;2:194. doi: 10.1111/j.2042-7166.1997.tb00734.x.", "ArticleIdList": ["10.1111/j.2042-7166.1997.tb00734.x"]}, {"Citation": "Mikolajczak P. Postep w badaniach nad wykorzystaniem surowcow roslinnych w terapii uzaleznienia alkoholowego. Herba Pol. 2006;4:133\u2013145."}, {"Citation": "Ulbricht C., Costa D., Dam C., D\u2019Auria D., Giese N., Isaac R., LeBlanc Y., Rusie E., Weissner W., Windsor R.C. An evidence-based systematic review of kudzu (Pueraria lobata) by the Natural Standard Research Collaboration. J. Diet. Suppl. 2015;12:36\u2013104. doi: 10.3109/19390211.2014.904123.", "ArticleIdList": ["10.3109/19390211.2014.904123", "24848872"]}, {"Citation": "Keung W.M., Vallee B.L. Daidzin and daidzein suppress free-choice ethanol intake by Syrian golden hamsters. Proc. Natl. Acad. Sci. USA. 1993;90:10008\u201310012. doi: 10.1073/pnas.90.21.10008.", "ArticleIdList": ["10.1073/pnas.90.21.10008", "PMC47702", "8234248"]}, {"Citation": "Lin R.C., Guthrie S., Xie C.-Y., Mai K., Lee D.Y., Lumeng L., Li T.-K. Isoflavonoid Compounds Extracted from Pueraria lobata Suppress Alcohol Preference in a Pharmacogenetic Rat Model of Alcoholism. Alcohol. Clin. Exp. Res. 1996;20:659\u2013663. doi: 10.1111/j.1530-0277.1996.tb01668.x.", "ArticleIdList": ["10.1111/j.1530-0277.1996.tb01668.x", "8800381"]}, {"Citation": "Penetar D.M., Toto L.H., Farmer S.L., Lee D.Y.-W., Ma Z., Liu Y., Lukas S.E. The isoflavone puerarin reduces alcohol intake in heavy drinkers: A pilot study. Drug Alcohol Depend. 2012;126:251\u2013256. doi: 10.1016/j.drugalcdep.2012.04.012.", "ArticleIdList": ["10.1016/j.drugalcdep.2012.04.012", "PMC3430804", "22578529"]}, {"Citation": "Lukas S.E., Penetar D., Berko J., Vicens L., Palmer C., Mallya G., Macklin E.A., Lee D.Y.-W. An Extract of the Chinese Herbal Root Kudzu Reduces Alcohol Drinking by Heavy Drinkers in a Naturalistic Setting. Alcohol. Clin. Exp. Res. 2005;29:756\u2013762. doi: 10.1097/01.ALC.0000163499.64347.92.", "ArticleIdList": ["10.1097/01.ALC.0000163499.64347.92", "15897719"]}, {"Citation": "Lukas S.E., Penetar D., Su Z., Geaghan T., Maywalt M., Tracy M., Rodolico J., Palmer C., Ma Z., Lee D.Y.-W. A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers. Psychopharmacology. 2013;226:65\u201373. doi: 10.1007/s00213-012-2884-9.", "ArticleIdList": ["10.1007/s00213-012-2884-9", "PMC3562758", "23070022"]}, {"Citation": "Bracken B.K., Penetar D.M., Maclean R.R., Lukas S.E. Kudzu root extract does not perturb the sleep/wake cycle of moderate drinkers. J. Altern. Complement. Med. 2011;17:961\u2013966. doi: 10.1089/acm.2010.0540.", "ArticleIdList": ["10.1089/acm.2010.0540", "PMC3233215", "22010780"]}, {"Citation": "Penetar D.M., Toto L.H., Lee D.Y.-W., Lukas S.E. A single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm. Drug Alcohol Depend. 2015;153:194\u2013200. doi: 10.1016/j.drugalcdep.2015.05.025.", "ArticleIdList": ["10.1016/j.drugalcdep.2015.05.025", "PMC4510012", "26048637"]}, {"Citation": "Oh J.H., Baek S.-E., Lee W.-Y., Baek J.Y., Trinh T.A., Park D.H., Lee H.L., Kang K.S., Kim C.-E., Yoo J.-E. Investigating the Systems-Level Effect of Pueraria lobata for Menopause-Related Metabolic Diseases Using an Ovariectomized Rat Model and Network Pharmacological Analysis. Biomolecules. 2019;9:747. doi: 10.3390/biom9110747.", "ArticleIdList": ["10.3390/biom9110747", "PMC6921005", "31752216"]}, {"Citation": "Jung H.W., Kang A.N., Kang S.Y., Park Y.-K., Song M.Y. The Root Extract of Pueraria lobata and Its Main Compound, Puerarin, Prevent Obesity by Increasing the Energy Metabolism in Skeletal Muscle. Nutrients. 2017;9:33. doi: 10.3390/nu9010033.", "ArticleIdList": ["10.3390/nu9010033", "PMC5295077", "28054981"]}, {"Citation": "Yang M., Hu Z., Yue R. Effect of pueraria, scutellaria, and coptis decoction for type 2 diabetes: A systematic review and meta-analysis protocol. Medicine. 2020;99:e19770. doi: 10.1097/MD.0000000000019770.", "ArticleIdList": ["10.1097/MD.0000000000019770", "PMC7220274", "32311982"]}, {"Citation": "Luo D., Dong X., Huang J., Huang C., Fang G., Huang Y. Pueraria lobata root polysaccharide alleviates glucose and lipid metabolic dysfunction in diabetic db/db mice. Pharm. Biol. 2021;59:382\u2013390. doi: 10.1080/13880209.2021.1898648.", "ArticleIdList": ["10.1080/13880209.2021.1898648", "PMC8018507", "33794128"]}, {"Citation": "Lertpatipanpong P., Janpaijit S., Park E.-Y., Kim C.-T., Baek S.J. Potential Anti-Diabetic Activity of Pueraria lobata Flower (Flos Puerariae) Extracts. Molecules. 2020;25:3970. doi: 10.3390/molecules25173970.", "ArticleIdList": ["10.3390/molecules25173970", "PMC7504745", "32878147"]}, {"Citation": "Jin S.E., Son Y.K., Min B.-S., Jung H.A., Choi J.S. Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots. Arch. Pharm. Res. 2012;35:823\u2013837. doi: 10.1007/s12272-012-0508-x.", "ArticleIdList": ["10.1007/s12272-012-0508-x", "22644850"]}, {"Citation": "Eom S.H., Jin S.-J., Jeong H.-Y., Song Y., Lim Y.J., Kim J.-I., Lee Y.-H., Kang H. Kudzu Leaf Extract Suppresses the Production of Inducible Nitric Oxide Synthase, Cyclooxygenase-2, Tumor Necrosis Factor-Alpha, and Interleukin-6 via Inhibition of JNK, TBK1 and STAT1 in Inflammatory Macrophages. Int. J. Mol. Sci. 2018;19:1536. doi: 10.3390/ijms19051536.", "ArticleIdList": ["10.3390/ijms19051536", "PMC5983698", "29786649"]}, {"Citation": "Wang S., Zhang S., Wang S., Gao P., Dai L. A comprehensive review on Pueraria: Insights on its chemistry and medicinal value. Biomed. Pharmacother. 2020;131:110734. doi: 10.1016/j.biopha.2020.110734.", "ArticleIdList": ["10.1016/j.biopha.2020.110734", "32942158"]}, {"Citation": "Larsson A., Engel J.A. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci. Biobehav. Rev. 2004;27:713\u2013720. doi: 10.1016/j.neubiorev.2003.11.010.", "ArticleIdList": ["10.1016/j.neubiorev.2003.11.010", "15019421"]}, {"Citation": "Engel J.A., Jerlhag E. Role of appetite-regulating peptides in the pathophysiology of addiction: Implications for pharmacotherapy. CNS Drugs. 2014;28:875\u2013886. doi: 10.1007/s40263-014-0178-y.", "ArticleIdList": ["10.1007/s40263-014-0178-y", "PMC4181507", "24958205"]}, {"Citation": "S\u00f6derpalm B., Ericson M. Neurocircuitry involved in the development of alcohol addiction: The dopamine system and its access points. Curr. Top. Behav. Neurosci. 2013;13:127\u2013161.", "ArticleIdList": ["22094880"]}, {"Citation": "Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656\u2013660. doi: 10.1038/45230.", "ArticleIdList": ["10.1038/45230", "10604470"]}, {"Citation": "Jerlhag E., Janson A.C., Waters S., Engel J.A. Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats. PLoS ONE. 2012;7:e49557.", "ArticleIdList": ["PMC3498203", "23166710"]}, {"Citation": "Overstreet D.H., Kralic J.E., Leslie Morrow A., Ma Z.Z., Zhang Y.W., Lee D.Y.W. NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT2C agonists. Pharmacol. Biochem. Behav. 2003;75:619\u2013625. doi: 10.1016/S0091-3057(03)00114-X.", "ArticleIdList": ["10.1016/S0091-3057(03)00114-X", "12895679"]}, {"Citation": "Bogdanov V.B., Bogdanova O.V., Dexpert S., Delgado I., Beyer H., Aubert A., Dilharreguy B., Beau C., Forestier D., Ledaguenel P., et al. Reward-related brain activity and behavior are associated with peripheral ghrelin levels in obesity. Psychoneuroendocrinology. 2020;112:104520. doi: 10.1016/j.psyneuen.2019.104520.", "ArticleIdList": ["10.1016/j.psyneuen.2019.104520", "31786481"]}, {"Citation": "Jerlhag E. Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse. Pharmacol. Ther. 2019;196:1\u201314. doi: 10.1016/j.pharmthera.2018.11.005.", "ArticleIdList": ["10.1016/j.pharmthera.2018.11.005", "30439457"]}, {"Citation": "Banks W.A., Tsch\u00f6p M., Robinson S.M., Heiman M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther. 2002;302:822\u2013827. doi: 10.1124/jpet.102.034827.", "ArticleIdList": ["10.1124/jpet.102.034827", "12130749"]}, {"Citation": "Abizaid A., Liu Z.-W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tsch\u00f6p M.H., et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Investig. 2006;116:3229\u20133239. doi: 10.1172/JCI29867.", "ArticleIdList": ["10.1172/JCI29867", "PMC1618869", "17060947"]}, {"Citation": "Skibicka K.P. The central GLP-1: Implications for food and drug reward. Front. Neurosci. 2013;7:181. doi: 10.3389/fnins.2013.00181.", "ArticleIdList": ["10.3389/fnins.2013.00181", "PMC3796262", "24133407"]}, {"Citation": "Suchankova P., Jerlhag E., Jayaram-Lindstr\u00f6m N., Nilsson S., Toren K., Rosengren A., Engel J.A., Franck J. Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence. PLoS ONE. 2013;8:e61242.", "ArticleIdList": ["PMC3620267", "23579732"]}, {"Citation": "Kern A., Albarran-Zeckler R., Walsh H.E., Smith R.G. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron. 2012;73:317\u2013332. doi: 10.1016/j.neuron.2011.10.038.", "ArticleIdList": ["10.1016/j.neuron.2011.10.038", "PMC3269786", "22284186"]}, {"Citation": "Edvardsson C.E., Vestlund J., Jerlhag E. A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus accumbens shell in rats. Eur. J. Pharmacol. 2021;899:174039. doi: 10.1016/j.ejphar.2021.174039.", "ArticleIdList": ["10.1016/j.ejphar.2021.174039", "33737011"]}, {"Citation": "Landgren S., Simms J.A., Hyyti\u00e4 P., Engel J.A., Bartlett S.E., Jerlhag E. Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addict. Biol. 2012;17:86\u201394. doi: 10.1111/j.1369-1600.2010.00280.x.", "ArticleIdList": ["10.1111/j.1369-1600.2010.00280.x", "21309944"]}, {"Citation": "Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. Addict. Biol. 2011;16:82\u201391. doi: 10.1111/j.1369-1600.2010.00231.x.", "ArticleIdList": ["10.1111/j.1369-1600.2010.00231.x", "PMC3015055", "20579004"]}, {"Citation": "Bahi A., Tolle V., Fehrentz J.-A., Brunel L., Martinez J., Tomasetto C.-L., Karam S.M. Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference. Peptides. 2013;43:48\u201355. doi: 10.1016/j.peptides.2013.02.008.", "ArticleIdList": ["10.1016/j.peptides.2013.02.008", "23428971"]}, {"Citation": "Mary S., Fehrentz J.-A., Damian M., Gaibelet G., Orcel H., Verdi\u00e9 P., Mouillac B., Martinez J., Marie J., Ban\u00e8res J.-L. Heterodimerization with Its Splice Variant Blocks the Ghrelin Receptor 1a in a Non-signaling Conformation. J. Biol. Chem. 2013;288:24656\u201324665. doi: 10.1074/jbc.M113.453423.", "ArticleIdList": ["10.1074/jbc.M113.453423", "PMC3750163", "23839942"]}, {"Citation": "Szulc M., Mikolajczak P.L., Geppert B., Wachowiak R., Dyr W., Bobkiewicz-Kozlowska T. Ethanol affects acylated and total ghrelin levels in peripheral blood of alcohol-dependent rats. Addict. Biol. 2013;18:689\u2013701. doi: 10.1111/adb.12025.", "ArticleIdList": ["10.1111/adb.12025", "23311595"]}, {"Citation": "Healey K.L., Landin J.D., Dubester K., Kibble S., Marquardt K., Brutman J.N., Davis J.F., Swartzwelder H.S., Chandler L.J. Effects of ethanol on plasma ghrelin levels in the rat during early and late adolescence. Alcohol. 2020;85:111\u2013118. doi: 10.1016/j.alcohol.2019.12.006.", "ArticleIdList": ["10.1016/j.alcohol.2019.12.006", "PMC7238721", "31923560"]}, {"Citation": "Orellana E.R., Piscura M.K., Horvath N., Hajnal A. Differential Response in Ethanol Behaviors of Female Rats Given Various Weight Loss Surgeries. Alcohol Alcohol. 2021;56:599\u2013604. doi: 10.1093/alcalc/agab054.", "ArticleIdList": ["10.1093/alcalc/agab054", "34343232"]}, {"Citation": "Kraus T., Schanze A., Gr\u00f6schl M., Bayerlein K., Hillemacher T., Reulbach U., Kornhuber J., Bleich S. Ghrelin levels are increased in alcoholism. Alcohol. Clin. Exp. Res. 2005;29:2154\u20132157. doi: 10.1097/01.alc.0000191753.82554.7e.", "ArticleIdList": ["10.1097/01.alc.0000191753.82554.7e", "16385185"]}, {"Citation": "Addolorato G., Capristo E., Leggio L., Ferrulli A., Abenavoli L., Malandrino N., Farnetti S., Domenicali M., D\u2019Angelo C., Vonghia L., et al. Relationship Between Ghrelin Levels, Alcohol Craving, and Nutritional Status in Current Alcoholic Patients. Alcohol. Clin. Exp. Res. 2006;30:1933\u20131937. doi: 10.1111/j.1530-0277.2006.00238.x.", "ArticleIdList": ["10.1111/j.1530-0277.2006.00238.x", "17067359"]}, {"Citation": "Badaoui A., De Saeger C., Duchemin J., Gihousse D., de Timary P., St\u00e4rkel P. Alcohol dependence is associated with reduced plasma and fundic ghrelin levels. Eur. J. Clin. Investig. 2008;38:397\u2013403. doi: 10.1111/j.1365-2362.2008.01947.x.", "ArticleIdList": ["10.1111/j.1365-2362.2008.01947.x", "18422979"]}, {"Citation": "Calissendorff J., Gustafsson T., Holst J.J., Brismar K., R\u00f6jdmark S. Alcohol intake and its effect on some appetite-regulating hormones in man: Influence of gastroprotection with sucralfate. Endocr. Res. 2012;37:154\u2013162. doi: 10.3109/07435800.2012.662662.", "ArticleIdList": ["10.3109/07435800.2012.662662", "22621425"]}, {"Citation": "Koob G.F. Animal models of craving for ethanol. Addiction. 2000;95:73\u201381. doi: 10.1080/09652140050111663.", "ArticleIdList": ["10.1080/09652140050111663", "11002904"]}, {"Citation": "Samson H.H. The microstructure of ethanol drinking: Genetic and behavioral factors in the control of drinking patterns. Addiction. 2000;95:61\u201372. doi: 10.1080/09652140050111654.", "ArticleIdList": ["10.1080/09652140050111654", "11002903"]}, {"Citation": "Spanagel R., Kiefer F. Drugs for relapse prevention of alcoholism: Ten years of progress. Trends Pharmacol. Sci. 2008;29:109\u2013115. doi: 10.1016/j.tips.2007.12.005.", "ArticleIdList": ["10.1016/j.tips.2007.12.005", "18262663"]}, {"Citation": "Heyser C.J., Schulteis G., Koob G.F. Increased Ethanol Self-Administration after a Period of Imposed Ethanol Deprivation in Rats Trained in a Limited Access Paradigm. Alcohol Clin. Exp. Res. 1997;21:784\u2013791. doi: 10.1111/j.1530-0277.1997.tb03840.x.", "ArticleIdList": ["10.1111/j.1530-0277.1997.tb03840.x", "9267526"]}, {"Citation": "Spanagel R. Alcohol addiction research: From animal models to clinics. Best Pract. Res. Clin. Gastroenterol. 2003;17:507\u2013518. doi: 10.1016/S1521-6918(03)00031-3.", "ArticleIdList": ["10.1016/S1521-6918(03)00031-3", "12828952"]}, {"Citation": "Mikolajczak P., Wiktorowicz K., Okulicz-Kozaryn I., Kostrzewa A., Kaminska E. Analysis of the distribution of peripheral blood lymphocyte subsets associated with chronic ethanol treatment in rats with a disturbed circadian cycle. Drug Alcohol Depend. 2000;60:303\u2013309. doi: 10.1016/S0376-8716(00)00116-2.", "ArticleIdList": ["10.1016/S0376-8716(00)00116-2", "11053765"]}, {"Citation": "Mikolajczak P., Okulicz-Kozaryn I., Nowaczyk M., Kaminska E. Ethanol facilitation of short-term memory in adult rats with a disturbed circadian cycle. Alcohol Alcohol. 2001;36:292\u2013297. doi: 10.1093/alcalc/36.4.292.", "ArticleIdList": ["10.1093/alcalc/36.4.292", "11468127"]}, {"Citation": "McGregor I.S., Gallate J.E. Rats on the grog: Novel pharmacotherapies for alcohol craving. Addict. Behav. 2004;29:1341\u20131357. doi: 10.1016/j.addbeh.2004.06.011.", "ArticleIdList": ["10.1016/j.addbeh.2004.06.011", "15345269"]}, {"Citation": "Piorunska-Mikolajczak A., Piorunska-Stolzmann M., Mikolajczak P., Okulicz-Kozaryn I., Kaminska E. Acamprosate involvement in triacylglycerol hydrolysis and transacylation with cholesterol in chronically ethanol-drinking rats. J. Basic Clin. Physiol. Pharmacol. 2004;15:153\u2013173. doi: 10.1515/JBCPP.2004.15.3-4.153.", "ArticleIdList": ["10.1515/JBCPP.2004.15.3-4.153", "15803955"]}, {"Citation": "Whitworth A.B., Fischer F., Lesch O.M., Nimmerrichter A., Oberbauer H., Platz T., Potgieter A., Walter H., Fleischhacker W.W. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet. 1996;347:1438\u20131442. doi: 10.1016/S0140-6736(96)91682-7.", "ArticleIdList": ["10.1016/S0140-6736(96)91682-7", "8676626"]}, {"Citation": "Mason B.J. Acamprosate and naltrexone treatment for alcohol dependence: An evidence-based risk-benefits assessment. Eur. Neuropsychopharmacol. 2003;13:469\u2013475. doi: 10.1016/j.euroneuro.2003.08.009.", "ArticleIdList": ["10.1016/j.euroneuro.2003.08.009", "14636963"]}, {"Citation": "Mason B.J., Goodman A.M., Chabac S., Lehert P. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: The role of patient motivation. J. Psychiatr. Res. 2006;40:383\u2013393. doi: 10.1016/j.jpsychires.2006.02.002.", "ArticleIdList": ["10.1016/j.jpsychires.2006.02.002", "16546214"]}, {"Citation": "Mann K., Kiefer F., Smolka M., Gann H., Wellek S., Heinz A., PREDICT Study Research Team Searching for responders to acamprosate and naltrexone in alcoholism treatment: Rationale and design of the PREDICT study. Alcohol. Clin. Exp. Res. 2009;33:674\u2013683. doi: 10.1111/j.1530-0277.2008.00884.x.", "ArticleIdList": ["10.1111/j.1530-0277.2008.00884.x", "19170666"]}, {"Citation": "Diehl A., Ulmer L., Mutschler J., Herre H., Krumm B., Croissant B., Mann K., Kiefer F. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients. Alcohol Alcohol. 2010;45:271\u2013277. doi: 10.1093/alcalc/agq017.", "ArticleIdList": ["10.1093/alcalc/agq017", "20348436"]}, {"Citation": "Kalk N.J., Lingford-Hughes A.R. The clinical pharmacology of acamprosate. Br. J. Clin. Pharmacol. 2014;77:315\u2013323. doi: 10.1111/bcp.12070.", "ArticleIdList": ["10.1111/bcp.12070", "PMC4014018", "23278595"]}, {"Citation": "Mason B.J. Alcohol Use Disorder: The Role of Medication in Recovery. Alc. Res. Curr. Rev. 2021;41 doi: 10.35946/arcr.v41.1.07.", "ArticleIdList": ["10.35946/arcr.v41.1.07", "PMC8184096", "34113531"]}, {"Citation": "Koltunowska D., Gibula-Bruzda E., Kotlinska J.H. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2013;45:242\u2013249. doi: 10.1016/j.pnpbp.2013.04.013.", "ArticleIdList": ["10.1016/j.pnpbp.2013.04.013", "23623810"]}, {"Citation": "Hu W., Morris B., Carrasco A., Kroener S. Effects of acamprosate on attentional set-shifting and cellular function in the prefrontal cortex of chronic alcohol-exposed mice. Alcohol. Clin. Exp. Res. 2015;39:953\u2013961. doi: 10.1111/acer.12722.", "ArticleIdList": ["10.1111/acer.12722", "25903298"]}, {"Citation": "Szulc M., Miko\u0142ajczak P., Okulicz-Kozaryn I., Kami\u0144ska E., Dyr W., Kostowski W. Acamprosate effect on short-term memory in chronically EtOH treated rats. Pol. J. Pharmacol. 2002;54:539\u2013540."}, {"Citation": "Gewiss M., Heidbreder C., Opsomer L., Durbin P., De Witte P. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol. 1991;26:129\u2013137. doi: 10.1093/oxfordjournals.alcalc.a045093.", "ArticleIdList": ["10.1093/oxfordjournals.alcalc.a045093", "1652250"]}, {"Citation": "Okulicz-Kozaryn I., Mikolajczak P., Kaminska E., Kaminska I., Szulc M., Bobkiewicz-Kozlowska T. Effect of naltrexone administration on short-term memory in chronically ethanol-treated outbred rats. Alcohol Alcohol. 2004;39:14\u201319. doi: 10.1093/alcalc/agh010.", "ArticleIdList": ["10.1093/alcalc/agh010", "14691068"]}, {"Citation": "Williams K.L., Woods J.H. Naltrexone reduces ethanol- and/or water-reinforced responding in rhesus monkeys: Effect depends upon ethanol concentration. Alcohol. Clin. Exp. Res. 1999;23:1462\u20131467. doi: 10.1097/00000374-199909000-00007.", "ArticleIdList": ["10.1097/00000374-199909000-00007", "10512311"]}, {"Citation": "Hein\u00e4l\u00e4 P., Alho H., Kiianmaa K., L\u00f6nnqvist J., Kuoppasalmi K., Sinclair J.D. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: A factorial double-blind, placebo-controlled trial. J. Clin. Psychopharmacol. 2001;21:287\u2013292. doi: 10.1097/00004714-200106000-00006.", "ArticleIdList": ["10.1097/00004714-200106000-00006", "11386491"]}, {"Citation": "Sinclair J.D. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol. 2001;36:2\u201310. doi: 10.1093/alcalc/36.1.2.", "ArticleIdList": ["10.1093/alcalc/36.1.2", "11139409"]}, {"Citation": "Benlhabib E., Baker J.I., Keyler D.E., Singh A.K. Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J. Med. Food. 2004;7:168\u2013179. doi: 10.1089/1096620041224210.", "ArticleIdList": ["10.1089/1096620041224210", "15298764"]}, {"Citation": "Benlhabib E., Baker J.I., Keyler D.E., Singh A.K. Effects of Purified Puerarin on Voluntary Alcohol Intake and Alcohol Withdrawal Symptoms in P Rats Receiving Free Access to Water and Alcohol. J. Med. Food. 2004;7:180\u2013186. doi: 10.1089/1096620041224102.", "ArticleIdList": ["10.1089/1096620041224102", "15298765"]}, {"Citation": "Keung W.M., Vallee B.L. Kudzu root: An ancient Chinese source of modern antidipsotropic agents. Phytochemistry. 1998;47:499\u2013506. doi: 10.1016/S0031-9422(97)00723-1.", "ArticleIdList": ["10.1016/S0031-9422(97)00723-1", "9461670"]}, {"Citation": "Overstreet D.H., Lee Y.W., Rezvani A.H., Pei Y.H., Criswell H.E., Janowsky D.S. Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Alcohol. Clin. Exp. Res. 1996;20:221\u2013227. doi: 10.1111/j.1530-0277.1996.tb01633.x.", "ArticleIdList": ["10.1111/j.1530-0277.1996.tb01633.x", "8730211"]}, {"Citation": "Keung W.M., Lazo O., Kunze L., Vallee B.L. Daidzin suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism. Proc. Natl. Acad. Sci. USA. 1995;92:8990\u20138993. doi: 10.1073/pnas.92.19.8990.", "ArticleIdList": ["10.1073/pnas.92.19.8990", "PMC41093", "7568058"]}, {"Citation": "Xiao B., Sun Z., Cao F., Wang L., Liao Y., Liu X., Pan R., Chang Q. Brain Pharmacokinetics and the Pharmacological Effects on Striatal Neurotransmitter Levels of Pueraria lobata Isoflavonoids in Rat. Front. Pharmacol. 2017;8 doi: 10.3389/fphar.2017.00599.", "ArticleIdList": ["10.3389/fphar.2017.00599", "PMC5591880", "28928659"]}, {"Citation": "Zhang Z., Li S., Jiang J., Yu P., Liang J., Wang Y. Preventive effects of Flos Perariae (Gehua) water extract and its active ingredient puerarin in rodent alcoholism models. Chin. Med. 2010;5:36. doi: 10.1186/1749-8546-5-36.", "ArticleIdList": ["10.1186/1749-8546-5-36", "PMC2984509", "20974012"]}, {"Citation": "Keung W.M., Lazo O., Kunze L., Vallee B.L. Potentiation of the bioavailability of daidzin by an extract of Radix puerariae. Proc. Natl. Acad. Sci. USA. 1996;93:4284\u20134288. doi: 10.1073/pnas.93.9.4284.", "ArticleIdList": ["10.1073/pnas.93.9.4284", "PMC39527", "8633056"]}, {"Citation": "Heyman G.M., Keung W.M., Vallee B.L. Daidzin decreases ethanol consumption in rats. Alcohol. Clin. Exp. Res. 1996;20:1083\u20131087. doi: 10.1111/j.1530-0277.1996.tb01950.x.", "ArticleIdList": ["10.1111/j.1530-0277.1996.tb01950.x", "8892531"]}, {"Citation": "Matkowski A., Wo\u017aniak D., Oszmia\u0144ski J., Lamer-Zarawska E. Flavonoids of Pueraria lobata: Chromatographic analysis of leaves and roots of cultivated plants. Pharmazie. 2003;58:682\u2013683.", "ArticleIdList": ["14531473"]}, {"Citation": "Zhang G., Ji J., Sun M., Ji Y., Ji H. Comparative Pharmacokinetic Profiles of Puerarin in Rat Plasma by UHPLC-MS/MS after Oral Administration of Pueraria lobata Extract and Pure Puerarin. J. Anal. Methods Chem. 2020;2020:4258156. doi: 10.1155/2020/4258156.", "ArticleIdList": ["10.1155/2020/4258156", "PMC7178524", "32351754"]}, {"Citation": "Szulc M., Mularczyk P., Kujawski R., Gryszczy\u0144ska A., Kami\u0144ska E., Geppert B., Baraniak J., Kania-Dobrowolska M., O\u017carowski M., Krajewska-Patan A., et al. Influence of salidroside, a neuroactive compound of Rhodiola rosea L., on alcohol tolerance development in rats. Herba Pol. 2018;64:22\u201334. doi: 10.2478/hepo-2018-0002.", "ArticleIdList": ["10.2478/hepo-2018-0002"]}, {"Citation": "Szulc M., Mularczyk P., Grzadzielski P., Zakowicz P., Kujawski R., Gryszczynska A., Buchwald W., Tezyk A., Krajewska-Patan A., Kaminska E., et al. Influence of extracts from Rhodiola rosea and Rhodiola kirilowii on the development of alcohol tolerance in rats. Herba Pol. 2018;64:34\u201343. doi: 10.2478/hepo-2018-0021.", "ArticleIdList": ["10.2478/hepo-2018-0021"]}, {"Citation": "Okulicz-Kozaryn I., Mikolajczak P., Kaminska E. Tolerance to hypothermia and hypnotic action of ethanol in 3 and 14 months old rats. Pharmacol. Res. 1992;25:63\u201364. doi: 10.1016/1043-6618(92)90288-M.", "ArticleIdList": ["10.1016/1043-6618(92)90288-M"]}, {"Citation": "Soyka M., Kranzler H.R., Berglund M., Gorelick D., Hesselbrock V., Johnson B.A., M\u00f6ller H.-J. WFSBP Task Force on Treatment Guidelines for Substance Use Disorders World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism. World J. Biol. Psychiatry. 2008;9:6\u201323. doi: 10.1080/15622970801896390.", "ArticleIdList": ["10.1080/15622970801896390", "18273737"]}, {"Citation": "Schuckit M.A. Alcohol-use disorders. Lancet. 2009;373:492\u2013501. doi: 10.1016/S0140-6736(09)60009-X.", "ArticleIdList": ["10.1016/S0140-6736(09)60009-X", "19168210"]}, {"Citation": "Landgren S., Engel J.A., Hyyti\u00e4 P., Zetterberg H., Blennow K., Jerlhag E. Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behav. Brain Res. 2011;221:182\u2013188. doi: 10.1016/j.bbr.2011.03.003.", "ArticleIdList": ["10.1016/j.bbr.2011.03.003", "21392542"]}, {"Citation": "Deschaine S.L., Farokhnia M., Gregory-Flores A., Zallar L.J., You Z.-B., Sun H., Harvey D.M., Marchette R.C.N., Tunstall B.J., Mani B.K., et al. A closer look at alcohol-induced changes in the ghrelin system: Novel insights from preclinical and clinical data. Addict. Biol. 2021:e13033. doi: 10.1111/adb.13033.", "ArticleIdList": ["10.1111/adb.13033", "PMC8548413", "33908131"]}, {"Citation": "Farokhnia M., Grodin E.N., Lee M.R., Oot E.N., Blackburn A.N., Stangl B.L., Schwandt M.L., Farinelli L.A., Momenan R., Ramchandani V.A., et al. Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals. Mol. Psychiatry. 2018;23:2029\u20132038. doi: 10.1038/mp.2017.226.", "ArticleIdList": ["10.1038/mp.2017.226", "29133954"]}, {"Citation": "Hicks M.P., Olive M. Whole genome transcriptional profiling of the mouse frontal cortex following repeated acamprosate administration; Proceedings of the 2nd WSEAS International Conference on Biomedical Electronics and Biomedical Informatics; Stevens Point, WI, USA. 20\u201322 August 2009; pp. 180\u2013183."}, {"Citation": "Zigman J.M., Elmquist J.K. Minireview: From anorexia to obesity\u2014The yin and yang of body weight control. Endocrinology. 2003;144:3749\u20133756. doi: 10.1210/en.2003-0241.", "ArticleIdList": ["10.1210/en.2003-0241", "12933644"]}, {"Citation": "Chen S.-R., Chen H., Zhou J.-J., Pradhan G., Sun Y., Pan H.-L., Li D.-P. Ghrelin receptors mediate ghrelin-induced excitation of agouti-related protein/neuropeptide Y but not pro-opiomelanocortin neurons. J. Neurochem. 2017;142:512\u2013520. doi: 10.1111/jnc.14080.", "ArticleIdList": ["10.1111/jnc.14080", "28547758"]}, {"Citation": "Gomez G., Englander E.W., Greeley G.H., Jr. Nutrient inhibition of ghrelin secretion in the fasted rat. Regul. Pept. 2004;117:33\u201336. doi: 10.1016/j.regpep.2003.09.003.", "ArticleIdList": ["10.1016/j.regpep.2003.09.003", "14687698"]}, {"Citation": "Pradhan G., Samson S.L., Sun Y. Ghrelin: Much more than a hunger hormone. Curr. Opin. Clin. Nutr. Metab. Care. 2013;16:619\u2013624. doi: 10.1097/MCO.0b013e328365b9be.", "ArticleIdList": ["10.1097/MCO.0b013e328365b9be", "PMC4049314", "24100676"]}, {"Citation": "Mikolajczak P., Okulicz-Kozaryn I., Szczawinska K., Kaminska E., Kus K. Zolpidem involvement on memory and hypnotic effect of ethanol in chronically ethanol-treated rats. Alcohol Alcohol. 1999;34:511\u2013519. doi: 10.1093/alcalc/34.4.511.", "ArticleIdList": ["10.1093/alcalc/34.4.511", "10456579"]}, {"Citation": "Daoust M., Lhuintre J.P., Moore N., Saligaut C., Flipo J.L., Boismare F. Is initial sensitivity to ethanol correlated with alcohol preference in alcohol-drinking and non-drinking rats? Alcohol Alcohol. 1987;22:409\u2013414.", "ArticleIdList": ["3426770"]}, {"Citation": "Crabbe J.C., Janowsky J.S., Young E.R., Kosobud A., Stack J., Rigter H. Tolerance to ethanol hypothermia in inbred mice: Genotypic correlations with behavioral responses. Alcohol. Clin. Exp. Res. 1982;6:446\u2013458. doi: 10.1111/j.1530-0277.1982.tb05007.x.", "ArticleIdList": ["10.1111/j.1530-0277.1982.tb05007.x", "6758616"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "22"}, {"Year": "2021", "Month": "12", "Day": "22"}, {"Year": "2021", "Month": "12", "Day": "22"}, {"Year": "2022", "Month": "1", "Day": "21", "Hour": "1", "Minute": "13"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "12", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["35056082", "PMC8777655", "10.3390/ph15010025", "ph15010025"]}}], "PubmedBookArticle": []}